Alivus Life Sciences Ltd vs Norris Medicines Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 1046 as of 13 Apr 15:30 . The P/E Ratio of Alivus Life Sciences Ltd changed from 13.4 on March 2022 to 27.2 on March 2025 . This represents a CAGR of 19.36% over 4 yearsThe P/E Ratio of Norris Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Alivus Life Sciences Ltd changed from ₹ 5624 crore on March 2022 to ₹ 13229 crore on March 2025 . This represents a CAGR of 23.84% over 4 yearsThe Market Cap of Norris Medicines Ltd changed from ₹ 6.5 crore on March 2021 to ₹ 16.78 crore on March 2025 . This represents a CAGR of 20.89% over 5 years The revenue of Alivus Life Sciences Ltd for the Dec '25 is ₹ 686.82 crore as compare to the Sep '25 revenue of ₹ 602.7 crore. This represent the growth of 13.96% The revenue of Norris Medicines Ltd for the Dec '25 is ₹ 3.27 crore as compare to the Sep '25 revenue of ₹ 2 crore. This represent the growth of 63.5% The ebitda of Alivus Life Sciences Ltd for the Dec '25 is ₹ 219.54 crore as compare to the Sep '25 ebitda of ₹ 193.89 crore. This represent the growth of 13.23% The ebitda of Norris Medicines Ltd for the Dec '25 is ₹ 0.95 crore as compare to the Sep '25 ebitda of ₹ -0.49 crore. This represent the decline of -293% The net profit of Alivus Life Sciences Ltd changed from ₹ 111.48 crore to ₹ 150.26 crore over 7 quarters. This represents a CAGR of 18.60% The net profit of Norris Medicines Ltd changed from ₹ -0.37 crore to ₹ 0.7 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 12.62 % on March 2025 . This represents a CAGR of -32.68% over 4 yearsThe Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Alivus Life Sciences Ltd

Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to 'Alivus Life Sciences Limited' on January 20, 2025. Nirma Limited is a Subsidiary of the Company.
The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business.

About Norris Medicines Ltd

Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
The Company was subsequently converted into Public Limited Company on March 7, 1992.
The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
Commercial production of the formulation unit commenced in Nov.'91.
The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

FAQs for the comparison of Alivus Life Sciences Ltd and Norris Medicines Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or Norris Medicines Ltd?

Market cap of Alivus Life Sciences Ltd is 12,733 Cr while Market cap of Norris Medicines Ltd is 14 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Norris Medicines Ltd?

The stock performance of Alivus Life Sciences Ltd and Norris Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and Norris Medicines Ltd?

As of May 4, 2026, the Alivus Life Sciences Ltd stock price is INR ₹1037.5. On the other hand, Norris Medicines Ltd stock price is INR ₹14.25.

How do dividend payouts of Alivus Life Sciences Ltd and Norris Medicines Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and Norris Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.